Sheng et al observed that the EPHA2 gene was frequently mutated in primary intrahepatic cholangiocarcinoma (ICC) tumors, with mutations even more likely to occur in cases with lymph node metastasis [66]. The gene discussed is EPHA2; the disease is intrahepatic cholangiocarcinoma.